Semaglutide* · GLP-1 Receptor Agonist*
Researchers seeking this product for laboratory research can explore PepGen-X.com as a supplier specializing in research-use compounds.
Semaglutide is a long-acting GLP-1 receptor agonist extensively studied for glucose regulation, appetite control, and body-weight reduction. Its effects include slowing gastric emptying, increasing glucose-dependent insulin secretion, and reducing appetite and food intake.
Research Benefits
Significant weight-loss research with clinical studies demonstrating substantial reductions in body weight
Blood-glucose regulation with significant improvements in HbA1c in people with type 2 diabetes
Appetite suppression through effects on central GLP-1 signaling and food intake
Cardiovascular research with demonstrated reduction in major cardiovascular events in certain high-risk populations
Multiple approved formulations including once-weekly injectable and daily oral formulations
Identified Risks & Side Effects
Gastrointestinal effects including nausea, vomiting, diarrhea, and constipation
Gallbladder-related problems including gallstones and cholecystitis
Pancreatitis has been reported and remains an important safety consideration
Thyroid C-cell tumor warning based on rodent findings; contraindicated in people with a personal or family history of medullary thyroid carcinoma or MEN 2
Weight regain can occur after discontinuation, particularly when ongoing treatment and lifestyle measures are stopped
Route: Subcutaneous or oral, depending on formulation | Frequency: Once weekly injection or daily oral formulation | FDA Status: FDA-approved for specific medical indications
Researcher Note
Semaglutide is one of the most extensively studied GLP-1 receptor agonists, with large clinical-trial programs supporting its effects on blood glucose, body weight, and cardiovascular outcomes. Its established clinical history makes it an important reference compound when comparing newer investigational metabolic peptides.
Disclaimer
FDA Status: FDA-approved for specific medical indications and formulations
Research Classification: Research use only
Compound Type: GLP-1 receptor agonist
All products are intended strictly for research and laboratory use only and are not intended for human or veterinary use.